Periprosthetic Fracture Registry (PPFx)
PPFx
Multicenter Prospective Registry for Periprosthetic Fractures After Hip or Knee Arthroplasty
1 other identifier
observational
600
6 countries
13
Brief Summary
This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty. A registry such as this ultimately aims to provide far-reaching benefits to society including reduced morbidity and mortality, improved patient safety, improved quality of care and medical decision-making, reduced medical spending, and advances in orthopaedic science.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2018
Longer than P75 for all trials
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2017
CompletedFirst Posted
Study publicly available on registry
December 20, 2017
CompletedStudy Start
First participant enrolled
December 31, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
September 12, 2025
September 1, 2025
8.1 years
November 14, 2017
September 8, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Classification of the fracture
Classification of the fracture using the UCS and some parts of the AO/OTA fracture classification system.
Pre-operatively (Day -1)
Secondary Outcomes (6)
Fracture mechanism
Pre-operatively (Day -1)
Rehabilitation program
Up to 12 months
Function of hip or knee
Up to 12 months
Health related quality of life
Up to 12 months
Fracture healing
Up to 12 months
- +1 more secondary outcomes
Eligibility Criteria
Patients with total or hemi hip or knee arthroplasty and who have a fracture around one of the arthroplasty
You may qualify if:
- Age ≥18 years
- Post-operative PPFx after total or hemi hip or total or unicondylar knee arthroplasty (including the acetabulum, femur, patella and proximal tibia) requiring
- osteosynthesis alone or
- component revision plus plate/nail osteosynthesis
- Informed consent obtained, i.e.:
- Ability of the patient or assigned representative to understand the content of the patient information / Informed Consent Form
- Signed and dated EC / IRB approved written informed consent
- Ability to attend post-operative follow up visits
You may not qualify if:
- Pregnancy or women planning to conceive within the study period
- Prisoner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (13)
University of Missouri Health Care
Columbia, Missouri, 65201, United States
Jersey City Medical Center RWJ Barnabas Health
Jersey City, New Jersey, 07302, United States
Saint Barnabas Medical Center Livingston
Livingston, New Jersey, 07039, United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Universitaire Ziekenhuiven Leuven
Leuven, Belgium
Hospital Santa Clara
Bogotá, Colombia
Charité Universitätsmedizin Berlin
Berlin, Germany
BG-Unfallklinik Ludwigshafen
Ludwigshafen, Germany
Universitätsklinikum Münster
Münster, Germany
Hospital Universitario Son Llàtzer
Palma de Mallorca, Spain
Universitätsspital Basel
Basel, Switzerland
Kantonspital Baselland
Liestal, 4410, Switzerland
Universitätsspital Zürich
Zurich, Switzerland
Related Publications (1)
Uzoigwe CE, Watts AT, Briggs P, Symes T. Periprosthetic Femoral Fractures-Beyond B2. J Am Acad Orthop Surg Glob Res Rev. 2024 Aug 6;8(8):e23.00135. doi: 10.5435/JAAOSGlobal-D-23-00135. eCollection 2024 Aug 1.
PMID: 39110721DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karl Stoffel, MD
Universitätsspital Basel
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2017
First Posted
December 20, 2017
Study Start
December 31, 2018
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
March 31, 2027
Last Updated
September 12, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share